The European Union is experiencing a notable shift within its medical device sector due to evolving regulatory frameworks, sparked by developments expected by early 2025. Beginning with a focus on key regulatory updates and industry responses, this transformation is deeply rooted in the frameworks
Introducing Ivan Kairatov, a distinguished authority in biopharmaceutical innovation and technological advancements. With extensive experience in research and development, Ivan provides a unique perspective on the acquisition of Althea by PCI Pharma. This interview delves into how such strategic
As the alternative protein industry strives to capture a significant share of the global protein market by 2035, optimizing bioprocessing emerges as a critical task. In an era where innovation is driven by sustainability and efficiency, manufacturers find themselves relying heavily on pump
The current landscape of the scientific and pharmaceutical industries presents a fascinating blend of unprecedented advancements and complex challenges that continue to redefine the sector. As these industries evolve, they encounter critical opportunities for growth alongside significant hurdles
The realm of advanced materials has witnessed a groundbreaking development with the introduction of molecular chainmail by researchers at Westlake University. Led by Professor Zhichang Liu, this innovative work in polymer science has resulted in a two-dimensional (2D) mechanically interlocked
The imposition of tariffs on pharmaceuticals presents a looming threat to medication costs and availability, especially considering Georgia's significant dependence on these imports. Initially exempt from recent global White House tariffs, this reprieve is under reconsideration, potentially leading
